Healthcare Equipment and Supplies
Company Overview of ev3 Inc.
ev3 Inc. develops, manufactures, and commercializes equipment, technologies, and solutions for the treatment of peripheral vascular and neurovascular diseases. It offers plaque excision systems, stents, carotid stents, percutaneous transluminal angioplasty balloons, embolic protection devices, thrombus management systems, blood clot therapy products, procedural support products, embolization coils, liquid embolics, micro catheters, thrombectomy catheters, occlusion balloons, guidewires, and retrieval devices. The company sells its products through a network of distributors in the Asia Pacific, Latin America, Eastern Europe, and the Middle East. ev3 Inc. was formerly known as Microvena Corpor...
3033 Campus Drive
Plymouth, MN 55441
Founded in 2000
Key Executives for ev3 Inc.
Chairman of Covidien, Chief Executive Officer of Covidien and President of Covidien
Senior Vice President of Operations
Compensation as of Fiscal Year 2014.
ev3 Inc. Key Developments
Back Bay Medical Inc. Enters into Settlement and License Agreement with EV3 Inc. and Covidien Holding Inc
Mar 2 15
WiLAN announced that the company's subsidiary, Back Bay Medical Inc., has entered into a settlement and license agreement with EV3 Inc. and Covidien Holding Inc. The agreement resolves litigation that was pending in the United States District Court for the Central District of California.
Back Bay Medical Inc. Enters into Settlement and License Agreement with EV3 Inc and Covidien Holding Inc
Mar 2 15
WiLAN announced that Back Bay Medical Inc., has entered into a settlement and license agreement with EV3 Inc. and Covidien Holding Inc. The agreement resolves litigation that was pending in the United States District Court for the Central District of California.
ev3 Agrees to Pay $1.25 Million to Settle a Federal Lawsuit
Feb 6 15
ev3 has agreed to pay $1.25 million to settle a federal lawsuit alleging that it wasted Medicare dollars. The medical device company EV3 is settling a whistleblower's claims that in 2006 and 2007, a company it acquired improperly coached hospitals across the country on how to overbill Medicare for minimally invasive procedures to remove hardened plaque from patients' arteries using one of its devices, called the Silver Hawk. Specifically, former sales representative Amanda Cashi alleged that the company told hospitals that 80% of their patients for the Silver Hawk procedure should stay overnight in the hospital following an atherectomy, leading to higher Medicare payments. The promises of higher reimbursement were intended to drive sales of Silver Hawk devices. Cashi and federal prosecutors who joined her lawsuit said most of the patients should have gotten lower-paying same-day procedures in an outpatient setting.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|